Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 3—March 2012


Community-associated Clostridium difficile Infections, Monroe County, New York, USA

Ghinwa DumyatiComments to Author , Vanessa Stevens, George E. Hannett, Angela D. Thompson, Cherie Long, Duncan MacCannell, and Brandi Limbago
Author affiliations: University of Rochester, Rochester, New York, USA (G. Dumyati, V. Stevens); State University of New York at Buffalo, Buffalo, New York, USA (V. Stevens); New York State Department of Health, Albany, New York, USA (G.E. Hannett); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A.D. Thompson, C. Long, D. MacCannell, B. Limbago)

Main Article

Table 3

Possible exposures to medications and health care during 12 weeks before diagnosis of CA-CDI in 42 patients, Monroe County, New York, USA, March 1–August 31, 2008*

Exposure No. (%)
Antimicrobial drugs 32 (76)
Penicillins 12 (31)
Clindamycin 7 (18)
Cephalosporins 5 (13)
Quinolones 5 (13)
Macrolides 4 (10)
Sulfa 3 (8)
Metronidazole 2 (5)
H2 blockers 1 (2)
PPI 11 (26)
Health care†
None 5 (12)
Outpatient visit 35 (83)
Physician office 29 (69)
Dentist 13 (31)
Emergency department visit 6 (14)
Visited a hospital or LTCF 9 (21)
Health care–related job 2 (5)

*CA-CDI, community-associated Clostridium difficile infection; PPI, proton pump inhibitor; LTCF, long-term care facility.
†Multiple exposures could be reported in the 12 weeks before CDI.

Main Article